Fluorotools creates new pharmacological tools to speed up and reduce the cost of developing new drugs tailored to each therapeutic target. To do this, they replace the radioactive tools that are commonly used with simpler ones that use fluorescence (an optical property that is helping to democratise drug discovery) instead of radioactivity, making them more environmentally friendly as well as more economical. They have three products in the pipeline that are ready to be marketed, and are currently in the betatester phase.